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The retromer complex is a protein complex that plays a central role in endosomal
trafficking. Retromer dysfunction has been linked to a growing number of neurological
disorders. The process of intracellular trafficking and recycling is crucial for maintaining
normal intracellular homeostasis, which is partly achieved through the activity of the
retromer complex. The retromer complex plays a primary role in sorting endosomal
cargo back to the cell surface for reuse, to the trans-Golgi network (TGN), or
alternatively to specialized endomembrane compartments, in which the cargo is not
subjected to lysosomal-mediated degradation. In most cases, the retromer acts as
a core that interacts with associated proteins, including sorting nexin family member
27 (SNX27), members of the vacuolar protein sorting 10 (VPS10) receptor family, the
major endosomal actin polymerization-promoting complex known as Wiskott-Aldrich
syndrome protein and scar homolog (WASH), and other proteins. Some of the molecules
carried by the retromer complex are risk factors for neurodegenerative diseases. Defects
such as haplo-insufficiency or mutations in one or several units of the retromer complex
lead to various pathologies. Here, we summarize the molecular architecture of the
retromer complex and the roles of this system in intracellular trafficking related the
pathogenesis of neurodegenerative diseases.
Keywords: retromer complex, sorting nexin family member 27, Wiskott-Aldrich syndrome protein and scar
homolog, Alzheimer’s disease, Parkinson’s disease
INTRODUCTION
Cargo originating from the plasma membrane (PM) and biosynthetic pathways is internalized to
endosomes through endocytosis, after which cargo proteins are recruited to different destinations
for many cellular activities. Internalized nutrients are targeted to different organelles for processing,
pathogens are transported into lysosomes for degradation, and newly synthesized proteins are
transported to specific cellular locations for specific functions (Lakadamyali et al., 2006).
The cargo sorting retromer complex, a membrane coat complex that is a crucial mediator of
endosomal protein sorting, was first identified in yeast as a peripheral membrane protein complex
(Seaman, 2004). Internalized cargoes are sorted by the retromer complex in three different ways
(Figure 1). First, in the recycling pathway, proteins such as nutrient transporters, mitogenic
signaling receptors, and cell adhesion receptors are recycled from endosomes to the PM for reuse
(Maxfield and McGraw, 2004; Hsu et al., 2012). The second pathway is a retrograde pathway in
which cargo is trafficked from the endosomes to the trans-Golgi network (TGN). The principal
cargoes of the retrograde pathways are sorting receptors, soluble N-ethylmaleimide-sensitive
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FIGURE 1 | The endosomal trafficking managed by retromer and the molecular architecture of inter-relationship between the retromer complex,
sorting nexin family member 27 (SNX27) and Wiskott-Aldrich syndrome protein and scar homolog (WASH) complex. (1) There are three trafficking
pathways regulated by retromer. Initially, the retrograde pathway, cargo proteins are retrieved from the endosomes and trafficked to the trans-Golgi network (TGN).
The second is the recycling pathway in which cargo proteins are trafficked to the plasma membrane (PM) for reuse. The first two transport routes above both via
tubules depended that extend out of edosomal membranes. The last pathway is degradative pathway, which helps in internalizing cargoes to the endosome then
gradually matures to become the multi-vesicular late endosome (LE) before fusing to existing lysosomes resulting in the degradation of cargoes in the endolysosome.
(2) The endosomal-sorting complex is composed of retromer complex, SNX27 and WASH complex. The WASH complex is comprised of five proteins: KIAA1033,
Strumpellin, FAM21, WASH1, and Coiled-Coil Domain Containing 53 (CCDC53). SNX27 is composed of protein-interaction domains often found in multi-domain
scaffolding proteins known as PDZ domain, the phoxhomology (PX) domain and the FERM domain. Retromer complex consist of cargo-selective complex (CSC;
VPS35, VPS26 and VPS29) and SNX-BAR (SNX1 or SNX2 and SNX5 or SNX6). VPS35 supports a platform that VPS26 and VPS29 bind to it. Rab7 interacts with
VPS26 and VPS35 as well as recruits the CSC to the endosome membrane. VPS26 binds to the PDZ domain of SNX27. The FERM-like domain of the SNX27 directly
interacts with SNX1 or SNX2 of SNX-BAR. The recruitment of SNX27 and SNX-BAR to endosomes is both through the binding of phosphatidylinositol-3-phosphate
(PI3P) by their PX domain. In addition, within the FERM domain of SNX27, is a second site with high affinity for PIP. As for the WASH complex, which is responsible
to link itself to the VPS35, VPS29 and SNX27 FERM domain through its unstructured C-terminal tail in FAM21 and is recruited by CSC.
factor attachment protein receptors (SNAREs), and other
molecules with functions dependent on continual retrieval from
the endosomal system and return to biosynthetic pathways
(Bonifacino and Rojas, 2006; Johannes and Popoff, 2008).
The third pathway is a degradative pathway that involves
internalization of cargoes on the PM into early endosomes (EEs),
which gradually mature into multi-vesicular late endosomes
(LEs) and fuse to existing lysosomes, resulting in degradation
of endolysosomal cargo (Cullen and Korswagen, 2012). The
retromer complex recruits membrane cargoes from the vacuolar
domain to retromer-decorated tubular domains for retrieval and
recycling; such cargoes can be selectively trafficked to avoid
transportation to LEs and subsequent degradation (Lu andHong,
2014). Therefore, the retromer complex plays a role in limiting
lysosome-mediated turnover. During this process, the retromer
complex recruits additional proteins that capture and package
cargoes and direct them to alternate sorting fates. Normally,
there is a coordinated relationship between the recycling,
retrograde, and degradative pathways, which maintains cellular
metabolic balance and homeostasis. However, if any of the
above-mentioned pathways are hampered by events such as
deregulated protein processing or missorting of intracellular
proteins within endosomal–lysosomal pathways, deficiencies in
cargo sorting, organelle development, and signal transduction
can occur, sometimes leading to protein misfolding disorders
(PMDs), including Alzheimer’s disease (AD), Parkinson’s disease
(PD), frontotemporal lobar degeneration (FTLD), and Down’s
syndrome (Reitz, 2015).
RETROMER AND ITS PARTNER PROTEINS
Sorting Nexin Bar (SNX-BAR)
Retromer is composed of two sub-protein complexes. In
addition to the cargo-selective complex (CSC), sorting nexins
Frontiers in Aging Neuroscience | www.frontiersin.org 2 March 2016 | Volume 8 | Article 42
Li et al. Role of Retromer Complex in Neurodegenerative Diseases
(SNX) form a hetero-dimer complex composed of vacuolar
protein sorting 5 (VPS5) and VPS17 in yeast (Seaman et al.,
1998). SNX proteins differ significantly between species. In
metazoans, SNX-BAR family members include SNX1, SNX2,
SNX5, and SNX6. SNX1 and SNX2 are VPS5 orthologs that
originated from gene duplication in a vertebrate ancestor;
however, SNX5 and SNX6 resulted from duplication of VPS17
in a metazoan ancestor (Harterink et al., 2011). All SNXs
include two membrane-binding domains, a phox homology
(PX) domain and Bin/Amphiphysin/Rvs domain (BAR), and
are thus termed SXN-BAR proteins. The BAR domain resides
at the C-terminal of SNX proteins. The PX domain is capable
of sensing, formatting, and stabilizing membrane curvature by
binding to membrane surfaces, leading to endosomal budding
in yeast and mammalian cells (Carlton et al., 2004; Frost et al.,
2009; van Weering et al., 2012). SNX-BAR dimers associate
with the membrane independently of the CSC in mammalian
cells (Seaman, 2004). SNX-BAR recruitment is mediated through
binding to phosphatidylinositol 3-phosphate (PtdIns(3)P) in EEs
in yeast and mammalian cells (Figure 1; Gillooly et al., 2000;
Cozier et al., 2002; Harterink et al., 2011; Vardarajan et al., 2012).
In LEs, phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2) is
bound by the PX domain of SNX-BAR dimers in yeast and
mammalian cells (Gillooly et al., 2000; Cozier et al., 2002; Huotari
and Helenius, 2011; Jean and Kiger, 2012).
In addition to mediating retrograde transport between
endosomes and the TGN, the SNX-BAR coat complex transports
other molecules through tubular-based endosomal trafficking
(Cullen, 2008). For example, SNX1 interacts with the tails of
G-protein-coupled receptors (GPCRs) in vitro and traffics the
GPCR protease-activated receptor-1 (PAR1) to the lysosome for
degradation. In addition, SNX1 regulates recycling of the P2Y1
receptor, a GPCR, via a slow recycling pathway in mammalian
cells (Wang et al., 2002; Heydorn et al., 2004; Nisar et al., 2010).
Cargo Selective Complex
In mammalian cells, the CSC is a highly conserved hetero-
trimer subcomplex consisting of VPS35, VPS26, and VPS29.
The CSC evolved in a common eukaryotic ancestor. Among
the three components of the CSC, VPS35 acts as the key
component, providing linkage between VPS26 and VPS29
(Figure 1). Mammals express two VPS26 orthologs, VPS26A and
VPS26B (Burd and Cullen, 2014), which possess an arresting
fold and bind to the highly conserved amino-terminal region
of VPS35 (Collins et al., 2005; Shi et al., 2006). However, an
L108P mutation within the PRLYL conserved assembly motif
of VPS35 blocks binding of VPS35 to VPS26 in yeast and
mammalian cells (Gokool et al., 2007). VPS29 possesses a
metallophosphoesterase fold and binds to the carboxy-terminal
of VPS35, where it is proposed to bind with the helical solenoid
of VPS35 in mammalian cells (Wang et al., 2005; Rojas et al.,
2008; Norwood et al., 2011). The loss of function of the D620N
VPS35 mutant was not as pronounced as that of the H675R
mutant, which cannot bind VPS29 in yeast or mammalian cells
(Zhao et al., 2007; Zavodszky et al., 2014). VPS35, VPS26, and
VPS29 form a trimeric complex that does not have intrinsic
membrane-binding activity. Retromer recruitment is mediated
by RAS-related GTP-binding proteins (RABs). In humans, Rab7
(Ypt7 in yeast) binds to LEs via direct interaction with N-
terminal conserved regions in VPS35 and VPS26. In addition,
amino-terminal residues (189–252) of VPS35 are essential for
Rab7-mediated retromer recruitment in mammalian cells (Priya
et al., 2015). In mammals, the binding sites of VPS35 and
VPS26 on Rab7 are near each other (Priya et al., 2015).
Importantly, association of VPS26 with VPS35 results in high
affinity binding between the CSC and activated Rab7 (Priya et al.,
2015). TBC1D5, a putative Rab GTPase-activating protein for
Rab7, inhibits recruitment of the retromer CSC in mammalian
cells (Rojas et al., 2008; Seaman et al., 2009; Vardarajan et al.,
2012).
However, in EEs, the CSC is recruited through SNX3 bound
to the membrane, where the retromer complex subsequently
transports integral membrane retrograde cargo (Harrison et al.,
2014). It would naturally follow that many membrane proteins
require retromer for their localization; indeed, a recent proteomic
study identified more than 100 proteins that were depleted from
the cell surface following loss of retromer function inmammalian
cells (Steinberg et al., 2013). In addition to sorting cargoes
through direct binding, CSC also sorts cargoes by recruitment
of accessory proteins, such as the Wiskott-Aldrich syndrome
protein and scar homolog (WASH) complex, as well as binding of
SNX27 with cargoes (Gomez and Billadeau, 2009; Harbour et al.,
2010).
Sorting Nexin 27 (SNX27)
SNX27 is composed protein-interaction domains often found in
multi-domain scaffolding proteins, including a PDZ domain, PX
domain, and FERM domain (Figure 1). The PX domain is a
phosphoinositide-binding domain that is conserved in yeast and
humans. The FERM domain, originally identified in rats as an
alternative-splicing product of the methamphetamine responsive
transcript 1 (Mrt1) gene, is a widespread cytoskeleton protein
module involved in localizing proteins to the PM in mammalian
cells (Kajii et al., 2003). In an arrangement unique among PX
domain proteins, the N-terminal PDZ domain of SNX27 is
upstream of the PX domain; three sub domains, F1, F2, and F3,
constitute the FERM-like domain at the C-terminal region of
SNX27 in mammals (Ghai et al., 2011). Two associations with
the SNX-BAR-retromer complex are displayed independently
by SNX27. In addition to direct interaction of the FERM-like
domain with SNX1 (and likely SNX2), the PDZ domain directly
binds to VPS26, whereas the FERM-like domain combines with
the unstructured C-terminal tail of FAM21, an unit of the
WASH retromer accessory protein complex, in mammalian cells
(Figure 1; Ghai et al., 2011).
In the pathway from endosomes to the PM, SNX27 acts as a
retromer adapter and a major regulator of transport via binding
with PDZ-binding motifs in mammalian cells (Cao et al., 1999;
Temkin et al., 2011; Steinberg et al., 2013). In this pathway,
the critical step is the recruitment of SNX27 to endosomes
through binding of phosphatidylinositol-3-phosphate (PI3P) by
the PX domain in T-cells (Ghai et al., 2015). In addition, the
FERM domain contains a second site with high affinity for
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PtdInsP species, which are enriched at the PM and within
LE compartments in T-cells. In other words, perturbing the
interaction of the FERM domain with PtdInsP significantly
reduces the association of SNX27 with endosomal recycling
compartments (Ghai et al., 2015). Further studies revealed that
an exposed β-hairpin in the PDZ domain of SNX27 in rats
engages a groove in the arrestin-like structure of VPS26 (Gallon
et al., 2014). This binding of SNX27 and VPS26 increases the
affinity of the SNX27 PDZ domain for PDZ-binding motifs by
an order of magnitude, revealing cooperation in cargo selection
(Gallon et al., 2014). Indeed, cargoes such as NPxY/NxxY
and a large group of G-protein coupled receptors (GPCRs)
were trafficked in an SNX27-dependent manner from EEs
to SNX-BAR-retromer-decorated tubules (Joubert et al., 2004;
Lunn et al., 2007; Lauffer et al., 2010; Balana et al., 2011;
Ghai et al., 2011; Temkin et al., 2011; Steinberg et al.,
2013).
Wiskott-Aldrich Protein and SCAR
Homolog (WASH) Complex
In addition to SNX27, the mammalian retromer complex
recruits another primary protein complex called WASH, which
contributes to precise trafficking of cargoes out of endosomes
(Gomez and Billadeau, 2009; Harbour et al., 2010; Cullen and
Carlton, 2012). The WASH complex was initially identified
through affinity isolation of tagged WASH1 protein. The
WASH complex is comprised of five proteins: KIAA1033
(also known as strumpellin and WASH-interacting protein
(SWIP)), strumpellin, FAM21, WASH1, and coiled-coil domain
containing 53 (CCDC53; Figure 1; Derivery et al., 2009; Gomez
and Billadeau, 2009). Each WASH complex component is
unstable and degrades if the other subunits are silenced in
mammalian cells (Derivery et al., 2009; Jia et al., 2010; Seaman
et al., 2013). These results strongly support the hypothesis that
the proteins operate as an obligate complex in which they
are dependent on each other (Gomez et al., 2012). FAM21
binds retromer through its unstructured C-terminal tail, which
contains numerous repeated motifs called LFa motifs, and binds
to the surface of endosomes in mammalian cells (Figure 1;
Harbour et al., 2012). The two most C-terminal LFa motifs,
R20 and R21, bind to the VPS35/VPS29 complex with the
highest affinity; endosomal localization of FAM21 is abolished
when R20 and R21 are deleted in mammalian cells (Jia et al.,
2012; Hao et al., 2013). In addition, VPS35-VPS29 interaction
is also critical for regulation of retromer association with the
WASH complex; the H675R mutation in human VPS35 blocks
binding to VPS29 and prevents association with FAM21 and the
WASH complex (Helfer et al., 2013). The results described above
suggest that CSC recruits the WASH complex to the endosomal
surface.
The WASH complex and activated Arp2/3 facilitate actin
polymerization and mediate patch formation on endosomes
(Derivery et al., 2009; Gomez and Billadeau, 2009). Discrete actin
patches may provide a platform for specialized signaling events;
rapid elongation of actin filaments can generate a localized
force that may be involved in the formation and maturation of
endosomal tubules through which internalized transmembrane
proteins are generally thought to exit the cell (Maxfield and
McGraw, 2004; Bonifacino and Rojas, 2006). Finally, Mvp1
promotes VPS1-mediated fission of retromer and coats tubules
that bud from the endosome (Chi et al., 2014). Therefore, WASH
plays a major role in retromer-dependent endosomal trafficking.
Recent studies have extended the CSC interactome (Steinberg
et al., 2013), but very few CSC interactomes have been subjected
to comprehensive study; therefore, further research is needed to
thoroughly study all CSC interactomes. Somemolecules reported
to interact with retromer or its accessory proteins play significant
roles in various neurodegenerative diseases.
RETROMER AND NEURODEGENERATIVE
DISEASES
Alzheimer’s Disease
AD is a major cause of dementia in the developed world.
Abnormal accumulation of neurotoxic amyloid beta (Aβ)
peptides produced by cleavage of amyloid precursor protein
(APP) is the hallmark of AD (Small and Duff, 2008). APP can
be processed through amyloidogenic and non-amyloidogenic
pathways. At the PM, most APP molecules are cleaved by
β-secretase, releasing soluble APP (sAPP). However some
precursor molecules escape this non-amyloidogenic pathway
and are internalized via the endocytic pathway, following
trafficking from endosomal compartments to the TGN or
endolysosomes. Within endosomal compartments and the TGN,
APP is sequentially cleaved by β-secretase (BACE) and γ-
secretase, resulting in formation of Aβ peptides of varying
lengths, including Aβ40 and Aβ42 (Choy et al., 2012).
In 2005, reduced protein levels of VPS35 and VPS26 were
found in the entorhinal cortex of brains from AD patients,
leading to increased focus on the role of retromer in AD
pathogenesis. In mice, VPS35 haploinsufficiency increases Aβ
protein levels, whereas deficiencies in the retromer-sorting
pathway increase the length of time that APP resides in
the endosomes; both effects can be linked to late-onset AD.
In flies, disruption of retromer function decreases secretion
of Aβ40, increasing the Aβ42:Aβ40 ratio and causing Aβ
to aggregate into neurotoxic oligomers and amyloid plaques,
leading to hippocampal-dependent memory deficits and synaptic
dysfunction (Small et al., 2005; Wen et al., 2011; Bhalla
et al., 2012; Vardarajan et al., 2012; Muhammad et al., 2008;
Sullivan et al., 2011). Therefore, retromer may take part in
APP metabolism, possibly by influencing trafficking of APP
from the endosomes to the TGN (Choy et al., 2012). Direct
binding between APP and the retromer complex has not
been reported (Andersen et al., 2005; Wen et al., 2011);
however, several proteins that participate in APP trafficking
and processing are dependent on retromer trafficking, including
sortilin-related receptors SORLA and SORCS1, BACE1, and
some phagocytosis receptors related to Aβ (Gustafsen et al.,
2013).
BACE1 and γ-secretase contribute critically to abnormal APP
metabolism. VPS35 dysfunction in the mouse hippocampus
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increased BACE1 activity, whereas suppression of BACE1
expression rescued VPS35 deficiency (Wen et al., 2011; Wang
et al., 2012). Suppression of VPS35 or VPS26 expression in
cultured cells decreased BACE1 trans-Golgi localization (Wen
et al., 2011). The VPS10p domain-sorting receptor sortilin is
also required for retromer-mediated retrieval of BACE1 from
endosomes to the TGN (Tan and Evin, 2012). Deletion of
the intracellular domain of sortilin, containing the putative
retromer-binding domain, increased endosomal localization of
sortilin and BACE1 (Lane et al., 2012). In addition, interfering
with SNX6 expression increased BACE1-dependent secretion of
sAPPand cell-associated fragment C99, as well as Aβ generation
(Okada et al., 2010). With respect to γ-secretase, SNX27
physically binds to PS1, a subunit of γ-secretase, and disrupts the
integrity of the complex, thus inhibiting APP proteolysis (Wang
et al., 2014). These results demonstrate the crucial function of
the retromer complex in suppression of AD neuropathology and
inhibition of BACE1 activation and Aβ production, which are
mediated by promoting BACE1 endosome-to-Golgi retrieval.
SorLA/LR11 belongs to a family of VPS10-containing
receptors and is expressed in neurons. Transcription of SORL1,
the gene encoding SORLA, is down-regulated in patients
suffering from sporadic AD. In addition, SORLA interacts
directly with APP in N2a cells (Scherzer et al., 2004; Andersen
et al., 2005; Schmidt et al., 2007; Mehmedbasic et al., 2015).
Ablation of sortilin expression in mice results in accumulation
of Aβ in the brain, implying that low SorLA expression may
be a risk factor for developing AD. SorLA slows the exit of
APP from the TGN into the secretory pathway, inhibiting
the formation of APP homodimers, the preferred substrates
of secretase (Figure 2; Rogaeva et al., 2007; Schmidt et al.,
2012). SORL1 acts as a molecular link between APP and
BACE and inhibits the interaction between BACE and APP
in the Golgi apparatus, reducing APP cleavage (Figure 2).
However, SorLA only inhibits APP processing when located
in the TGN, where its CR-cluster is essential for binding;
deletion of the CR-cluster abolishes the protective effects of
SorLA against APP processing (Fjorback and Andersen, 2012;
Mehmedbasic et al., 2015), indicating that SorLA functions
as a TGN retention factor for APP. Retromer mediates
retrograde transport of SorLA through direct interaction
between VPS26 and the cytoplasmic tail of SorLA; when
this interaction is disrupted, SorLA can be transported to
the TGN and interact with newly synthesized APP (Fjorback
and Andersen, 2012). Consequently, overexpression of SorLA
may reduce the abundance of Aβ and inhibit Aβ aggregation,
perhaps slowing the progression of neurodegeneration associated
with AD.
FIGURE 2 | Retromer-mediated sorting in Alzheimer’s disease (AD). In microglia, retromer regulates the recycling pathway of phagocytic receptors to the cell
surface for reuse, such as CD36 which can promote Aβ clearance. Retromer dysfunction decreases the recycle efficiency of phagocytic receptors, which leads to
microglia abnormalities. BACE is response to cleave the amyloid precursor protein (APP) to Aβ (of varying lengths), and BACE is more activity in endosomes
compartments because of low PH. In neuron, retromer retrievals its sorting receptor SorLA and SorLA from endosomes to TGN. (1) SorCS1 modulates retrograde
TGN trafficking of APP from endosomal compartments resulting in increased APP localization to the TGN and decreased Aβ. (2) SorLA functions in slowing APP exit
from the TGN into the secretory pathway whereby interacts with APP blocks the ability of APP to form homodimers, which are the preferred substrates of secretase.
Secondly, SORL1 acts as a molecular link between APP and BACE and inhibits BACE interacts with APP in Golgi, which reduces cleavage of APP.
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SorCS1 is a VPS10 domain-containing protein that shows
significantly reduced expression levels in amygdala from AD
brains. In cultured cells, SorCS1 interacts with APP and regulates
Aβ generation (Reitz et al., 2011). In the brains of wild-type
mice, SorCS1 forms a complex with APP, SorL1, and VPS35
(Lane et al., 2013). In the brains of female SorCS1-deficient mice,
VPS35 abundance is decreased, while Aβ abundance is increased,
providing further evidence of the role of SorCS1 in regulating
Aβ generation and implicating retromer in such regulation (Lane
et al., 2010). Initially, reduced SorCS1 expression facilitated
APP processing by γ-secretase (Reitz et al., 2011). SorCS1
modulates retrograde TGN trafficking of APP and/or APP
C-terminal fragments (CTF) from endosomal compartments
(Figure 2); its cytoplasmic tail motif YAQM facilitated APP
localization to the TGN and decreased Aβ production in H4
neuroglioma cells (Lane et al., 2013). Therefore, within low pH
endosomal compartments, especially in LEs, APP is cleaved by
BACE and γ-secretase, followed by formation of Aβ (Xu, 2009).
However, sorting of SorCS1 from endosomes to the TGN is
dependent on retromer (Figure 2; Hermey, 2009; Lane et al.,
2013). In addition, retromer may also take part in SorCS1-
dependent endosome-to-lysosome trafficking of APP/APPCTFs.
The results described above demonstrate that low expression
levels of SORLA and SORCS1 causes pathogenic processing
of APP by decreasing the time that APP resides in the TGN;
therefore, we hypothesize that increasing expression of SORLA
and SORCS1 or facilitating trafficking of these proteins from
endosomes to the TGN might have protective effects against
AD.
Apart from impacting APP processing, recent studies found
that microglia from the brains of human patients with AD
exhibit reduced retromer expression and a decreased rate of Aβ
phagocytosis. Phagocytosis receptors, including CD36, tripartite
motif containing 2 (Trim2), and class A1 scavenger receptors
(Scara1), function in the clearance of extracellular proteins,
including Aβ (Prada et al., 2006; Frenkel et al., 2013; Lucin
et al., 2013). During the process of phagocytosis, phagocytosis
receptors interact with ligands and are taken into the cell.
Subsequently, phagocytosis receptors are recycled to the PM
for reuse (Freeman and Grinstein, 2014). Therefore, to some
extent, the recycling efficiency of the phagocytosis receptor
controls the clearance efficiency of its ligand. Decreased retromer
expression impacts the recycling efficiency of CD36 and Trim2
from endosomes to the PM, inhibiting Aβ clearance (Figure 2;
Lucin et al., 2013). The results described above suggest that
recovering the abundance of retromer in the microglia of AD
patients may enhance phagocytic efficiency and induce removal
of Aβ aggregates.
Other AD risk genes, including SNX1, SNX3, and RAB7A, are
involved in the cargo-selective retromer complex, demonstrating
the direct link between the activity of the retromer complex and
the pathogenesis of AD (Vardarajan et al., 2012).
Parkinson’s Disease
PD is the second most common neurodegenerative disease
worldwide after AD. PD is associated with two main pathological
hallmarks: loss of pigmented dopaminergic (DA) neurons in the
substantia nigra pars compacta and the presence of Lewy bodies
composed primarily of α-synuclein (αSYN) fibrils (Spillantini
et al., 1997).
Utilizing exosome sequencing, two independent research
groups identified the same mutation in the VPS35 gene
(P.D620N) as the first disease-causing gene for PD (Vilariño-
Güell et al., 2011). In the following years, the D620N mutation
in VPS35 was identified, leading researchers to focus on this
mutation as the probable disease-causing pathogenic gene in
autosomal dominant familial or late-onset autosomal dominant
PD patients (Vilariño-Güell et al., 2011; Zimprich, 2011; Ando
et al., 2012). Overexpression of VPS35 or VPS26 significantly
protected VPS35DAT-Cre mice from locomotor deficits, while
increasing the shortened life span of Drosophila serving as a
model of PD (Linhart et al., 2014; Miura et al., 2014; Tang et al.,
2015). In addition, VPS35 protein suppressed αSYN expression
in a prion-like seeding model in transgenic mice, protecting the
mice from neurodegeneration (Linhart et al., 2014; Ross et al.,
2015). Finally, the retromer complex can mask the toxic effects
of alterations in levels of translation initiation factor expression
(Ross et al., 2015). These results suggest that retromer plays a
crucial role in the development of PD.
Two studies suggest that loss of DA neurons in patients with
PD is caused by mitochondrial dysfunction. In DA neurons,
VPS35 deficiency, loss, or mutation (P.D620N) increased the
half-life and protein level of mitochondrial E3 ubiquitin ligase-1
(MUL1) and led to mitofusin-2 (MFN2) ubiquitination and
degradation, thus leading to mitochondrial fragmentation and
DA neuron loss (Tang et al., 2015). Another study verified that
mitochondrial deficits in neurons were caused by P.D620N-
enhanced interaction of the dynamin-like protein 1 (DLP1)
complex with VPS35, resulting in abnormal transport of DLP1
to the lysosomes for degradation (Wang et al., 2016). DLP1 is
as an inhibitor of mitochondrial fission events (Chan, 2006).
Synaptic dysfunction may also lead to neuronal death. The
p.D620N mutation inhibits recycling of AMPA-type glutamate
receptors (AMPARs), which mediate the vast majority of
excitatory transmission within CNS to the PM (Figure 3).
Such perturbations to synaptic function likely produce chronic
pathophysiological stress upon neuronal circuits that may
contribute to neurodegeneration in this form, and other forms
of Parkinsonisms (Munsie et al., 2015). The studies described
above demonstrate that retromer defects lead to neuron
death.
The pathogenic oligomers formed by various intermediate
states of αSYN are suspected to be the toxic species underlying
PD. FcγRIIB contributes to phagocytosis of αSYN into the
cell (Wales et al., 2013; Choi et al., 2015). Aspartyl protease
cathepsin D (CTSD), a lysosomal enzyme, is responsible
for degradation of long-lived αSYN (Cullen et al., 2009).
Under physiological conditions, cation-independentmannose-6-
phosphate receptor (CI-M6PR) is mainly localized in the TGN
and LEs in the perinuclear space. Newly synthesized CTSD
binds CI-M6PR in the TGN and is subsequently translocated
into endosomes (Figure 3). Once at the endosomes, CTSD is
released from CI-M6PR and awaits the next opportunity for
transport to the lysosomes, at which point it becomes active
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FIGURE 3 | The role of retromer in trafficking of AMPAR, ATG9A and
CI-MPR. Firstly, retromer is response for recycle of AMPA type glutamate
receptor (AMPAR) to the PM that mediates vast majority of excitatory
transmission with CNS and excitatory synaptic transmission. Secondly,
Retromer in charge of transport autophagy-related protein ATG9A to the
autophagosomes, mutation p.D620N affects ATG9A localization and
trafficking results in impaired autophagosomes formation. Finally, retromer
retrieves unoccupied CI-MPRs in endosomes and traffics them to the TGN,
where they take part in cycles of CTSD to the lysosomes.
(Figure 3; Miura et al., 2014). Retromer retrieves unoccupied CI-
M6PRs from endosomes and traffics them to the TGN, where
they take part in further cycles of CTSD sorting (Figure 3).
However, p.D620N leads to a perturbation of CI-M6PR in
endosome-to-TGN transport and results in a more scattered
distribution of CI-M6PR in the periphery, markedly impacting
processing of CTSD into the mature 20 kDa active form and
thus leading to abnormal αSYN accumulation (Follett et al.,
2014; McGough et al., 2014; Zavodszky et al., 2014). Silencing
of VPS35 in cultured cells also reduced the distribution of
CI-MPR and impairs maturation of CTSD concomitant with
striking accumulation of αSYN in the lysosomes, which may
contribute to the pathogenesis of PD (Miura et al., 2014).
Autophagosomes have been implicated as an intracellular
site in which aggregations of αSYN are cleared. In 2012,
Dengjel used quantitative proteomics to identify VPS35 as
a stimulus-dependent interacting partner of autophagosomes
in human breast cancer cells, while a more recent study
demonstrated that VPS35 directly interacts with and retrieves
Atg8 inMagnaporthe oryzae (Dengjel et al., 2012). These studies
suggest that retromer is closely related to the formation of
autophagosomes in mammalian cells. Because p.D620N poorly
binds with the WASH complex and impairs recruitment of
WASH to endosomes, the affinity of p.D620N/VPS29 to R20
and R21 was significantly lower than that of the wild-type
VPS35/VPS29 (McGough et al., 2014). This poor affinity affects
autophagy-related protein ATG9A trafficking (Figure 3), while
localization to the autophagosome impairs autophagosome
formation, perhaps causing accumulation of αSYN (Zavodszky
et al., 2014; Munsie et al., 2015). Although VPS26A and VPS29
interact with VPS35 in the CSC in the retromer complex, only
two rare nonsynonymous variants (VPS26A, p.K93E; andVPS29,
p.N72H) were identified in 702 PD patients, suggesting that
mutations in VPS26A and VPS29 are not a frequent cause of
PD (Koschmidder et al., 2014; Shannon et al., 2014; Gustavsson
et al., 2015). VPS35 interacts genetically and functionally with
translation initiator EIF4G1, a PD gene and scaffold protein
on which the translation initiation complex assembles (Dhungel
et al., 2015; Ross et al., 2015). Expression of VPS35 or sortilin
proteins can suppress toxicity associated with EIF4G1 up-
regulation, masking the toxic effects of alterations in levels
of translation initiation factor expression (Dhungel et al.,
2015).
The studies mentioned above suggest that malfunction of
VPS35 plays a primary role in the pathogenesis of PD, implying
that overexpression of VPS35may inhibit the development of PD
and extend the lifespan of PD patients.
Other Neurodegenerative Diseases
Retromer participates in the pathogenesis of neurological
disorders other than AD and PD. In hereditary spastic
paraplegia, three disease-causing mutations, V626F, L619F, and
N471D, have been described in highly conserved sequences
of strumpellin. Mutant strumpellin increases the vulnerability
of corticospinal neurons, a pathological feature of hereditary
spastic paraplegia (Freeman et al., 2013). In Down syndrome
caused by over-expression of miR-155, a chromosome 21-
encodedmicro RNAnegatively regulates C/EBPβ, a transcription
factor that modulates SNX27 expression. Reduced SNX27
expression impacts glutamate receptor recycling to the PM in
the hippocampus and produces grossly abnormal neuroanatomy,
leading to synaptic dysfunction and deficits in learning and
memory (Wang et al., 2013).
Endosomal transport of various pathogens, such as
Salmonella, Herpesvirus saimiri, Coxiella burnetii, human
papilloma virus, Legionella pneumophila, and Shiga toxins, is
also mediated by the CSC (Bujny et al., 2007, 2008; Popoff et al.,
2007; Kingston et al., 2011; Finsel et al., 2013; McDonough et al.,
2013). Several pathogens interact directly with retromer, but the
manner in which retromer interacts with many of its substrates
is unknown.
Conclusions and Future Perspectives
The trend in pathophysiological research on neurodegenerative
diseases is shifting from studying disease-specific, causative,
misfolded proteins towards determining the pathways and
protein complexes that may contribute to the pathogenesis of
such diseases.
Interestingly, most neurodegenerative diseases have a close
relationship with retromer complex defects (reduced expression
or mutations). Reduced retromer levels were found in several
parts of the brains of patients with AD or PD, suggesting that
reduced retromer abundance may have been associated with
these conditions. Therefore, future studies should determine
the potential of retromer as a therapeutic target for treatments
intended for patients with neurological disorders.
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In patients with AD, PD, and prion diseases, inhibition of
microglial phagocytosis results in aggregation of Aβ, αSYN,
and prion protein (PrPSc; Ciesielski-Treska et al., 2004; Lucin
et al., 2013; Choi et al., 2015). Several studies found that
inhibition of microglial phagocytosis by defects in various
receptors and proteins that participated in phagocytosis resulted
in neurodegeneration and amyloidosis in mouse models of
AD (Lu and Lemke, 2001; Wyss-Coray et al., 2002; Kaifu
et al., 2003; Heneka et al., 2013). In contrast, microglial
activation reduced Aβ pathology in mouse models of AD
(Heneka et al., 2013). Retromer is critically involved in recycling
phagocytosis receptors, including CD36, Trem2, and CED-1,
to the PM for reuse; such recycling is vital for the clearance
of misfolded proteins and cellular debris (Chen et al., 2010;
Lucin et al., 2013; Abduljaleel et al., 2014). Increased abundance
of retromer facilitated phagocytosis and reduced Aβ plaque
formation in the brains of APP transgenic mice by increasing the
efficiency of phagocytosis receptor recycling (Lucin et al., 2013).
These studies highlight the importance of retromer-mediated
phagocytosis in brain homeostasis and suggest that retromermay
represent a therapeutic target for the treatment of neurological
diseases.
Retromer may also be a therapeutic target for treatments
intended to relieve neuronal damage associated with
neurodegenerative diseases. VPS35-deficiency leads to neuron
loss in Tg2576 mice and DA neuron loss in young adult mice
(Wen et al., 2011). However, deficient mitochondrial dynamics
associated with neurodegenerative disorders is a factor in neuron
loss (Tang et al., 2015). VPS35 plays a role in the formation of
mitochondria-derived vesicles, suggesting that mitochondria
may be a potential target site for VPS35 function. Expression
of wild-type WVPS35 in VPS35-deficient cells restored
mitochondrial morphology and function in DA neurons, as
well as mitochondrial fission dynamics in fibroblasts (Tang et al.,
2015; Wang et al., 2016). VPS35 suppressed MUL1-mediated
MFN2 degradation and promoted mitochondrial fusion
(Züchner et al., 2004; Tang et al., 2015). However, MFN2-loss
is implicated in the pathogenesis of Charcot-Marie-Tooth
disease type 2A (Züchner et al., 2004). Altered mitochondrial
morphology and dynamics were detected in VPS35-deficient
DA neurons, as well as VPS35-depleted neuroblastoma and
fibroblast cell lines (Tang et al., 2015; Wang et al., 2016).
These results suggest that VPS35 may be a general regulator of
mitochondrial fusion and fission dynamics in vitro, indicating
that it could be a therapeutic target for treatments intended
to prevent neuron loss in patients with neurodegenerative
diseases.
In addition to the diseases mentioned above, retromer also
plays a role in Creutzfeldt-Jakob disease (CJD), diabetes, and
optic nerve injury (Kipkorir et al., 2014; Liu et al., 2014; Morabito
et al., 2014). Future studies should determine why substantially
decreased retromer expression was found in several parts of the
brains of patients with the diseases mentioned above, but not in
the whole brain. In addition, future studies should attempt to
determine why retromer dysfunction occurs in specific neuronal
populations. Comprehensive clinical studies are required to
determine the potential of retromer as a therapeutic target.
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